Background: Protooncogene CD117 is a cytokine receptor important for hematopoietic element development. Currently, we are not able to routinely separate a sufficient quantity of bone marrow CD117 + cells for experimental purposes.
INTRODUCTION
CD117 (KIT/C-kit receptor) is a cytokine receptor expressed on the surface of hematopoietic stem cells 1, 2 . Signalling through CD117 has an influence on cell survival, proliferation, and differentiation and plays an important role in hematopoietic element development. CD117 is a protooncogene and its overexpression or mutation can lead to cancer 1, 2 . Percentage estimation of CD117 + elements in bone marrow samples is already routinely made using flow cytometry as a step in the patient's immunophenotype profiling. However, we are not able to separate a sufficient quantity of CD117 + cells during routine processes for further experimental uses. One of the applications CD117 + cells is study of the expression of apoptosis regulating proteins such as the BCl-2 protein family which is important for normal development of blood cells 3 . One generally accepted method for isolating cells is immunomagnetic separation 4 .
AIM
To establish an immunomagnetic separation method for CD117
+ hematopoietic stem cells and to estimate the expression of BCl-2 family proteins in human bone marrow samples.
MATERIAL AND METHODS
The bone marrow samples were acquired from the Hemato-Oncology Clinic, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital, Olomouc. The biopsy of the bone marrow was taken as part of routine diagnosis and was approved by the local Ethics Committee.
We took 120 samples of 1-2 ml of bone marrow harvested in 10 ml of RPMI medium (Sigma Aldrich, St. Louis, MO, USA), enriched by 500 μl 7,5% NaHCO 3 (Sevapharma, Prague, CZ) and 200 μl heparin (500 IU/ ml), (Zentiva, Prague, CZ). Briefly, the mononuclear cells were acquired by the Histopaque ® gradient centrifugation (Sigma-Aldrich, Prague, CZ). Murine bone marrow was acquired from the C57/BL6 mouse. Healthy mice were sacrificed, the total bone marrow was extracted and a mononuclear suspension was prepared as described above.
We used the magnetic separation system from the StemCell Technologies TM (Vancouver, Canada) described by Wognum et al. 4 , Chen et al. 5 . Shortly, the system consists of a magnet generating a strong magnetic field and a tube containing the cell suspension. The cell suspension is incubated with the antibody aimed at the antigen of interest. The antibody is then crossed with the magnetic nanoparticles and the labelled cell suspension is then placed into the magnet. After 5 minutes the supernatant is poured off and the positively labelled cells remain in the tube. The cells are then washed several times. The recommended starting quantity for the separation process is between 10 8 and 10 9 cells. The amount of separated cells was assessed by flow cytometric analysis (BD FACSCalibur TM system, BD Biosciences, Franklin Lakes, NJ, USA).
Mononuclear cells were obtained from newly diagnosed chronic myeloid leukemia (CML) patients and CD33 staining (Santa Cruz Biotechnology, Santa Cruz, CA, USA, dilution 1:50) was used as marker of myeloid cell population 6 . Cytospin slides were prepared as follows: (cytocentrifugation, 600 RPM), fixed in methanol : acetone (1:1) for 5 minutes and subsequently CD117 (Santa Cruz Biotechnology, Santa Cruz, CA, USA, dilution 1:50) was stained by indirect double-step immunocytochemistry with FITC conjugated secondary antibody (Jackson Immuno Research, West Grove, PA, USA, dilution 1:50). The nuclei were counterstained by DAPI (Millipore, Billerica, MA, USA). Also CD33 (Santa Cruz Biotechnology, Santa Cruz, CA, USA, dilution 1:50) antigen was labelled, the secondary antibody was used as described above. Selected BCL-2 family proteins [BCl-2 (Biogenex, San Ramon, CA, USA, dilution 1:100), BAX (Santa Cruz Biotechnology, Santa Cruz, CA, USA, dilution 1:50)] were stained by indirect three step immunofluorescence [secondary antibody biotinylated anti-mouse IgG (H+L) (Jackson Immuno Research, West Grove, PA, USA), Texas Red ® dye conjugated Streptavidin (Vector Laboratories, Burlingame, CA, USA)].
Cell suspension staining: the cell suspension was spread directly onto a microscopic slide before fixation and immunostaining (see above cytospin staining).
RESULTS AND DISCUSSION
The flow cytometry analysis showed that we separated only 2.6 % CD117 + cells (Fig. 1 ) from human bone marrow which is insufficient for further experiments. For this Hematopoietic stem cell separation for experimental purposes -methodic limitations reason, we decided to establish immunomagnetic cell separation from murine material but the amount of separated cells was also insufficient (1 %). We then did the cytospin for the detection of cells of interest. Although the cytospin was done carefully, the fragile blood elements were destroyed. Therefore, the most simple methodical approach -cell suspension staining was selected. Mononuclear cells from the newly diagnosed CML patient were chosen for this staining. As we expected, due to the large number of immature cells, CD117 positivity was found in 70 % of the mononuclear elements (Fig. 2) . CD33 positivity was counted in 60 % of mononuclear cells. Further, the labelling of the Bcl-family proteins showed antiapoptotic BCl-2 expression in 80 %, in contrast to proapoptotic BAX which had weak positivity (approximately 5 %) (Fig. 3) . Therefore, we assumed that the large number of CD117 + cells was a result of the leukaemic origin of the cells.
CONCLUSIONS
Our results show, that CD117 immunomagnetic separation from residual bone marrow material is not acceptable for experimental purposes. The initial number of cells does not fulfill the conditions for the separation process. Our results demonstrated that the only practical approach for bone marrow cell examination (morphology and immunophenotype) is cell suspension staining which reveals both the distribution of cytoplasmic proteins and surface antigens of the immature blood elements.
